Continuous Lenalidomide and Low-Dose Dexamethasone for the Treatment of Patients with Newly Diagnosed Multiple Myeloma and Renal Impairment in the First Trial

Meletios A Dimopoulos; Matthew C. Cheung; Murielle Roussel; Ting Liu; Barbara Gamberi; Brigitte Kolb; Hans Günter Derigs; Hyeon‐Seok Eom; Karim Belhadj; Pascal Lenain; Richard van der Jagt; Sophie Rigaudeau; R. Hall; Arnaud Jaccard; Axel Tosikyan; Lionel Karlin; Jack W. Singer; Rik Schots; G. Chen; J Marek; Annette Ervin‐Haynes; Thierry Façon

doi:10.1016/j.clml.2015.07.339

Related publications

Article2015

Continuous Treatment With Lenalidomide and Low-Dose Dexamethasone for Patients With Transplant-Ineligible Newly Diagnosed Multiple Myeloma in the First Trial: Impact of Age

Cyrille Hulin, Chaim Shustik, Andrew Belch, Maria Teresa Petrucci, Ulrich Dührsen, Jin Lu, Kevin Song, Philippe Rodon, Laurent Garderet, Hannah Hunter, I Azaïs, Richard Eek, Margaret Macro, Shaker R. Dakhil, Vanessa Houck, G. Chen, Annette Ervin‐Haynes, Fritz Offner, Meletios A Dimopoulos, Thierry Façon

Article2014

Impact of Renal Impairment (RI) on Outcomes after Treatment (Tx) with Lenalidomide and Low-Dose Dexamethasone (Rd) in Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts): First Trial Results

Meletios A Dimopoulos, Matthew C. Cheung, Murielle Roussel, Ting Liu, Barbara Gamberi, Brigitte Kolb, Hans Guenter Derigs, Hyeon Seok Eom, Karim Belhadj, Pascal Lenain, Richard H. van der Jagt, Sophie Rigaudeau, Mamoun Dib, R. Hall, Arnaud Jaccard, Axel Tosikyan, Lionel Karlin, William Bensinger, Rik Schots, Guang Chen, Jennifer Marek,

Article2012

Continuous Lenalidomide Treatment for Newly Diagnosed Multiple Myeloma

Antonio Palumbo, Roman Hájek, Michel Delforge, Martin Kropff, Maria Teresa Petrucci, John Catalano, Heinz Gisslinger, W Wiktor-Jędrzejczak, Mamia Zodelava, Katja Weisel, Nicola Cascavilla, Genadi Iosava, Michèle Cavo, Janusz Kłoczko, Joan Bladé, Meral Beksaç, Ivan Špıčka, Torben Plesner, J. Radke, Christian Langer, Dina Ben Yehuda, Alessandro Corso, Lindsay Herbein, Zhinuan Yu, Jay Mei, ,

Article2014

LENALIDOMIDE plus LOW-DOSE DEXAMETHASONE (RD) VS. MELPHALAN-PREDNISONE-THALIDOMIDE (MPT) IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) PATIENTS (PTS): THE FIRST TRIAL

Thierry Façon, Meletios A Dimopoulos, Angela Dispenzieri, J. Catalano, Andrew R. Belch, C. Hulin, Michèle Cavo, A. De Lorenzo Pinto, Katja Weisel, H. Ludwig, NJ Bahlis, A. Baños, Mourad Tiab, Michel Delforge, John Cavenagh, Catarina Geraldes, J. J Lee, C Chen, Albert Oriol, Javier de la Rubia, Lugui Qiu, Darell White,

Article2015

Effect of age on efficacy and safety outcomes in patients with newly diagnosed multiple myeloma receiving lenalidomide and low-dose dexamethasone (RD): the first trial

C. Hulin, Chaim Shustik, Andrew R. Belch, MT Petrucci, Ulrich Duehrsen, Jiamei Lu, Kihwan Song, Philippe Rodon, Brigitte Pegourié, Laurent Garderet, HM Hunter, I Azaïs, Richard Eek, Margaret Macro, Shaker R. Dakhil, Houck, G Chen, Annette Ervin‐Haynes, Fritz Offner, Meletios A Dimopoulos, Thierry Façon